[Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
D001161:Arteriosclerosis / Q000188:drug therapy*; D003327:Coronary Disease / Q000209:etiology; D004357:Drug Synergism; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000209:etiology; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use*
D009539:Nicotinic Acids; D006493:Heparin; D013806:Theophylline
Beeinflussung der Fett-Klärinsuffizienz bei hyperlipämischer Atherosklerose.